Pre Diagnostics AS is a new company determined to develop and commercialize an innovative and highly effective diagnostic test for AD. Founded by a highly experienced biotech team, Pre Diagnostics owns the licensed rights to a patent-protected new diagnostic test from the Norwegian university hospital AHUS.

The company will:

• Pursue cost-efficient product development with external partners, enabling public funding opportunities
• Collaborate with AHUS researchers on clinical development trials
• Pursue sales to leading pharma companies in addition to renowned diagnostic companies

Pre Diagnostics is an innovative Norwegian diagnostic company that seeks to create value for patients, partners and investors by developing pioneering and patient-friendly in-vitro diagnostic (IVD) products for early detection of diseases.

The company’s proprietary concept holds that a disease evokes systemic responses in macrophages in the blood unique for the disease that can be accurately measured in blood samples.

Pre Diagnostics aims to be a leader in diagnosing early Alzheimer’s disease and focuses on the development of IVD biomarker products that use established and effective technologies and procedures.

The company protects its technology through an evolving patent portfolio.